Premium
Ciprofloxacin‐induced immune‐mediated thrombocytopenia: No cross‐reactivity with gemifloxacin
Author(s) -
Sim D. W.,
Yu J. E.,
Jeong J.,
Koh Y.I.
Publication year - 2018
Publication title -
journal of clinical pharmacy and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.622
H-Index - 73
eISSN - 1365-2710
pISSN - 0269-4727
DOI - 10.1111/jcpt.12596
Subject(s) - ciprofloxacin , gemifloxacin , discontinuation , medicine , immune thrombocytopenia , levofloxacin , immune system , antibiotics , immunology , microbiology and biotechnology , platelet , biology
Summary What is known and objective Fluoroquinolone‐induced immune‐mediated thrombocytopenia is uncommon, and no reports of cross‐reactivity among fluoroquinolones exist. Here, we describe a case of ciprofloxacin‐induced immune thrombocytopenia with no cross‐reactivity with gemifloxacin. Case description A 77‐year‐old woman showed profound thrombocytopenia immediately after two ciprofloxacin injections for pneumonia. Platelet counts recovered rapidly after ciprofloxacin discontinuation. She had experienced thrombocytopenia after ciprofloxacin administration 4 years earlier, which was assumed to be ciprofloxacin‐induced immune‐related. Interestingly, no thrombocytopenia occurred following the subsequent exposure to another fluoroquinolone, gemifloxacin. What is new and conclusion No cross‐reactivity occurred between ciprofloxacin and gemifloxacin in this fluoroquinolone‐induced immune thrombocytopenia case.